Lobe Sciences Ltd. (CVE:LOBE)

BRIEF

published on 03/05/2026 at 13:45, 5 hours 19 minutes ago

Lobe Sciences Ltd. Announces Participation at Miami Healthcare Conferences

Healthcare Conférences Biopharmaceutical Miami Therapeutic Programs
PRESS RELEASE

published on 03/05/2026 at 13:40, 5 hours 24 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Lobe Sciences announces CEO availability for meetings during Jefferies and Leerink Healthcare Conferences in Miami. Company focuses on advancing therapeutic programs for medical needs

Lobe Sciences Jefferies Conference Therapeutic Programs CEO Availability Leerink Healthcare Conference
BRIEF

published on 02/03/2026 at 13:05, 1 month 2 days ago

Lobe Sciences Reports Q1 2026 Financial Results and Initiatives

Drug Development R&D Investment Financial Summary Lobe Sciences Q1 2026 Results
PRESS RELEASE

published on 02/03/2026 at 13:00, 1 month 2 days ago

Lobe Sciences Reports First Quarter 2026 Results and Highlights
Lobe Sciences Ltd. reports unaudited financial results for Q1:2026, with increased R&D activities and improved operating efficiency. The Company advances development programs in diseases with unmet medical needs

Financial Results R&D Activities Operating Efficiency Medical Needs Lobe Sciences Ltd.
BRIEF

published on 01/13/2026 at 13:05, 1 month 23 days ago

Lobe Sciences Strengthens Board with Appointment of Nick Karakochuk

Corporate Governance Biopharmaceutical Board Appointment Lobe Sciences Nick Karakochuk
PRESS RELEASE

published on 01/13/2026 at 13:00, 1 month 23 days ago

Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
Lobe Sciences Ltd. appoints Mr. Nick Karakochuk to Board of Directors in strategic move. Mr. Karakochuk brings expertise in governance, capital markets, and complex transactions

Board Of Directors Governance Capital Markets Lobe Sciences Nick Karakochuk
BRIEF

published on 01/08/2026 at 15:00, 1 month 28 days ago

Lobe Sciences Reports Financial Gains and Strategic Focus in FY2025

Financial Results Strategic Focus Balance Sheet Subsidiary Programs FY2026 Outlook
PRESS RELEASE

published on 01/08/2026 at 14:55, 1 month 28 days ago

Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
Lobe Sciences reports strengthened balance sheet and strategic advancements in fiscal year 2025, focusing on financial results, progress since leadership transition, and core development programs

Balance Sheet Development Programs Fiscal Year 2025 Strategic Advancements Lobe Sciences
BRIEF

published on 01/06/2026 at 12:05, 1 month 30 days ago

Lobe Sciences Announces FY2025 Results and Strategic Transformation

Financial Results Strategic Transformation Lobe Sciences Sickle Cell Disease Psilocin Development
PRESS RELEASE

published on 01/06/2026 at 12:00, 1 month 30 days ago

Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
Lobe Sciences Ltd. reports fiscal year 2025 audited financial results, significant balance sheet improvements, and strategic transformation initiatives. Details on key financial highlights and operational progress provided

Financial Results Operational Progress Balance Sheet Strategic Transformation Lobe Sciences Ltd.

1 2 ... 4

Published on 03/05/2026 at 17:55, 1 hour 9 minutes ago

ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026
Published on 03/05/2026 at 14:00, 5 hours 4 minutes ago

EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 5 hours 4 minutes ago

GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 5 hours 4 minutes ago

Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 13:40, 5 hours 24 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

View all ACCESSWIRE

Published on 03/05/2026 at 18:48, 15 minutes ago

POS-Transaction in Own Shares
Published on 03/05/2026 at 18:17, 46 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 03/05/2026 at 17:57, 1 hour 6 minutes ago

EQS-Adhoc: Delivery Hero SE may redeem convertible bonds in H1 2026 using proceeds from a USD 1.5bn increase of its term loans subject to certain conditions
Published on 03/05/2026 at 17:48, 1 hour 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/05/2026 at 17:45, 1 hour 18 minutes ago

Swiss Prime Site announces the conversion price of its CHF 350 million green convertible bonds due 2032 and the outcome of the incentivized conversion invitation

View all EQS

Published on 03/05/2026 at 18:40, 24 minutes ago

2025 Full-year results FREY: a pan-European platform already creating value
Published on 03/05/2026 at 18:34, 29 minutes ago

Mersen: Number of shares and voting rights as of February 28, 2026
Published on 03/05/2026 at 17:45, 1 hour 19 minutes ago

February 2026
Published on 03/05/2026 at 17:45, 1 hour 19 minutes ago

Cie du Bois Sauvage : Results 2025
Published on 03/05/2026 at 13:20, 5 hours 43 minutes ago

Voting rights

View all LES ECHOS COMFI WIRE

News